School of Medicine
Showing 331-340 of 360 Results
-
Elisa Mariel Visher
Postdoctoral Scholar, Genetics
Current Research and Scholarly InterestsElisa Visher is broadly interested in the (co)evolution of life history strategies, niche breadth, diversification, and adaptability. They use mostly experimental evolution methods in microbial systems to test the predictions and assumptions of theoretical literature. Currently, they am especially interested in understanding the genetics of trade-offs in microbes to better understand patterns of diversity in nature and constraints to adaptation.
-
Douglas Vollrath
Professor of Genetics and, by courtesy, of Ophthalmology
Current Research and Scholarly InterestsThe Vollrath lab works to uncover molecular mechanisms relevant to the health and pathology of the outer retina. We study metabolic and other cellular interactions between the glial-like retinal pigment epithelium (RPE) and adjacent photoreceptors, with the goals of understanding the pathogenesis of photoreceptor degenerative diseases such as age-related macular degeneration and retinitis pigmentosa, and developing therapies.
-
Katarzyna Wac
Affiliate, Genetics
BioKatarzyna Wac, Full Professor of Computer Science
Quality of Life Technologies lab, Geneva School of Economics and Management, Center for Informatics, University of Geneva, Switzerland
Research Vision: Leveraging behavioural markers to quantify and improve individuals’ Quality of Life in new ways – drawing on new emerging models from computer science incorporating examination, diagnosis, and treatment of daily life as an “organ” – much like a cardiologist examines heart - and the resulting Quality of Life as a "longitudinal vital sign" - routinely reported for patients and non-patients alike. -
Tao Wang (王韬)
Research Scientist, Genetics
Current Role at StanfordPrincipal Investigator, AI for Precision Diabetes Management
Project Manager & Scientific Co-lead, PsychENCODE Project
Project Initiator & Clinical Co-lead, Long COVID Clinical RCT with TCM
Project Initiator & Manager, AI & Wearables Toolkit for Biomedical Sciences
ENCODE and PsychENCODE Project Data Manager
Research Scientist, US Veteran Affairs Hospital
SCGPM HPC System Administrator -
Shannon White
Postdoctoral Scholar, Genetics
BioHi, I'm Shannon White. I began my postdoctoral fellowship in Michael Snyder's lab in the fall of 2020. I received my PhD from Georgetown University in Tumor Biology in Chunling Yi's lab. My graduate worked explore the signaling and metabolic vulnerabilities of NF2-mutant tumors following YAP/TAZ depletion. My postdoctoral work is exploring the epigenetic hallmarks that contribute to colon cancer progression and drug resistance. I am developing colon organoids derived from pre-cancerous polyp tissue collected from Familial Adenomatous Polyposis patients as a model system to investigate epigenetic and signaling responses to chemoprevention treatments.
-
Monte Winslow
Associate Professor of Genetics and of Pathology
Current Research and Scholarly InterestsOur laboratory uses genome-wide methods to uncover alterations that drive cancer progression and metastasis in genetically-engineered mouse models of human cancers. We combine cell-culture based mechanistic studies with our ability to alter pathways of interest during tumor progression in vivo to better understand each step of metastatic spread and to uncover the therapeutic vulnerabilities of advanced cancer cells.
-
John Witte
Professor of Epidemiology and Population Health, of Biomedical Data Science and, by courtesy, of Genetics
BioDr. Witte joined the Stanford community in July 2021. In addition to serving as Vice Chair and professor in the Department of Epidemiology & Population Health, and as a professor of Biomedical Data Science and, by courtesy, of Genetics, he will also serve as a member of the Stanford Cancer Institute.
Dr. Witte is an internationally recognized expert in genetic epidemiology. His scholarly contributions include deciphering the genetic and environmental basis of prostate cancer and developing widely used methods for the genetic epidemiologic study of disease. His prostate cancer work has used comprehensive genome-wide studies of germline genetics, transcriptomics, and somatic genomics to successfully detect novel variants underlying the risk and aggressiveness of this common disease. A key aspect of this work has been distinguishing genetic factors that may drive increased prostate cancer risk and mortality among African American men. Providing an avenue to determine which men are more likely to be diagnosed with clinically relevant prostate cancer and require additional screening or specific treatment can help reduce disparities in disease prevalence and outcomes across populations. Dr. Witte has also developed novel hierarchical and polygenic risk score modeling for undertaking genetic epidemiology studies. These advances significantly improve our ability to detect disease-causing genes and to translate genetic epidemiologic findings into medical practice.
Dr. Witte has received the Leadership Award from the International Genetic Epidemiology Society (highest award), and the Stephen B. Hulley Award for Excellence in Teaching. His extensive teaching portfolio includes a series of courses in genetic and molecular epidemiology. He has mentored over 50 graduate students and postdoctoral fellows, serves on the executive committees of multiple graduate programs, and has directed a National Institutes of Health funded post-doctoral training program in genetic epidemiology for over 20 years. Recently appointed to the National Cancer Institute Board of Scientific Counselors, Dr. Witte has been continuously supported by the National Institutes of Health.
